Source:http://linkedlifedata.com/resource/pubmed/id/10867173
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-7-19
|
pubmed:abstractText |
A polyclonal antibody, M5, to the hydrophilic loop domain of human presenilin 1 (PS1) was prepared. Western blot and immunoprecipitation analyses showed that M5 specifically recognized the processed C-terminal fragment, but not the full-length PS1. Epitope mapping analysis revealed that the essential sequence for recognition of the C-terminal fragment by M5 is DPEAQRR (302-308). The recognition of the C-terminal fragment by M5 in a processing-dependent manner was further confirmed by competitive enzyme-linked immunosorbent assay using the synthetic peptide L281 (281-311), which contains the putative processing site and the preceding amino acids to the site. Although L281 contains the epitope sequence for M5, the maximum inhibition was only 14%. Immunocytochemistry using M5 combined with hL312, which recognizes both full-length PS1 and the C-terminal fragment, allowed us to distinguish the localization of the processed C-terminal fragment from that of full-length PS1. Confocal microscopy demonstrated that the full-length form of wild-type PS1 is preferentially located in the nuclear envelope, while the processed C-terminal fragment is mainly present in the endoplasmic reticulum (ER). However, PS1 with familial Alzheimer's disease-associated mutations could not translocate to the nuclear envelope, and both the full-length and processed mutants were co-localized in the ER.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0168-0102
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
101-11
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10867173-Alzheimer Disease,
pubmed-meshheading:10867173-Amino Acid Sequence,
pubmed-meshheading:10867173-Biological Transport,
pubmed-meshheading:10867173-Blotting, Western,
pubmed-meshheading:10867173-Humans,
pubmed-meshheading:10867173-Immunohistochemistry,
pubmed-meshheading:10867173-Membrane Proteins,
pubmed-meshheading:10867173-Microscopy, Confocal,
pubmed-meshheading:10867173-Molecular Sequence Data,
pubmed-meshheading:10867173-Mutation,
pubmed-meshheading:10867173-Nuclear Envelope,
pubmed-meshheading:10867173-Peptide Fragments,
pubmed-meshheading:10867173-Precipitin Tests,
pubmed-meshheading:10867173-Presenilin-1,
pubmed-meshheading:10867173-Tissue Distribution,
pubmed-meshheading:10867173-Transfection,
pubmed-meshheading:10867173-Tumor Cells, Cultured
|
pubmed:year |
2000
|
pubmed:articleTitle |
Familial Alzheimer's disease-associated mutations block translocation of full-length presenilin 1 to the nuclear envelope.
|
pubmed:affiliation |
Laboratory for Alzheimer's Disease, Brain Science Institute, RIKEN, 351-0198, Saitama, Japan. tohonda@rc.m-kagaku.co.jp
|
pubmed:publicationType |
Journal Article
|